TransWorld Med Corporation was formed with the medical objective of dramatically improving the quality of life through innovative technology.
Significant reduction in patient mortality will be achieved by the company's patented devices and algorithms. The noninvasive techniques and monitoring methodologies will be very useful in preventing hospitalizations and adverse outcomes associated with the painful biopsies currently utilized by the medical industry for these patients. TransWorld Med will facilitate the lowering of health costs for patients while appreciably improving their quality of life. This device and technology will therefore be easily embraced by physicians, insurance companies, and governmental third party payers. Extension of these medical technologies into other chronic disease processes will have a similar economic cost savings impact.
TransWorld Med Corporation is aimed at improving the quality of life through innovative technology. We will employ advanced medical and technological sciences to reduce patient mortality and hospitalizations and increase mobility with portable medical care and monitoring endeavors. We will strive to improve medical quality and reduce healthcare costs.
The TransWorld Med Corporation management team brings a depth of proven experience developing innovative medical products and building a successful medical device company. Represented in the backgrounds of most of our team are some Fortune 100 companies such as; Johnson & Johnson, Medtronic, and Guidant.